WHO ICTRP trial
A Randomized, Double-blind, Placebo-Controlled Study in China to evaluate the…
ChiCTR2300071848 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300071848 |
|---|---|
| Public title | A Randomized, Double-blind, Placebo-Controlled Study in China to evaluate the efficacy and safety of VGX-3100 Delivered Intramuscularly (IM) followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-16 and/or HPV-18 related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix |
| Scientific title | A Randomized, Double-blind, Placebo-Controlled Study in China to evaluate the efficacy and safety of VGX-3100 Delivered Intramuscularly (IM) followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-16 and/or HPV-18 related High Grade Squamous Intraepithelial Lesion (HSIL) of the… |
| Primary sponsor | Chinese Academy of Medical Sciences Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | High Grade Squamous Intraepithelial Lesion of the Cervix |
| Interventions | Test Group: 6 mg (1 ml) VGX-3100 intramuscular injection followed by EP with the CELLECTRA 5PSP device given at Day 1, Week 4 and Week 12;Control Group:Placebo intramuscular injection followed by EP with the CELLECTRA 5PSP device given at… |
| Registration date | May 26, 2023 |
| Target size | Test Group:56;Control Group:28 |
| Secondary IDs | CTR20201547 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: